Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp (Nasdaq: FLAC) is a blank-check company sponsored by Frazier Life Sciences, a dedicated life sciences investment firm with a long track record in healthcare and biopharma. The SPAC completed its initial public offering in 2021, targeting acquisition opportunities within the life sciences and biotechnology sectors. FLAC filed a quarterly report on Form 10-Q with the SEC on November 9, 2022, reflecting its status as an active blank-check company continuing its search for a business combination target at that time. The vehicle was part of a broader wave of sector-focused life sciences SPACs that emerged during the 2020–2022 market cycle. Sign up at SpacDesk for full filings history, deal timelines, and real-time data on FLAC and hundreds of other SPACs.